Use-effectiveness of the female versus male condom in preventing sexually transmitted disease in women

Sexually Transmitted Diseases

Volumn 30, Issue 5, 2003, Pages 433-439

  French, P P ^a,b,e   Latka, M ^c,f   Gollub, E L ^a,g   Rogers, C ^a   Hoover, D R ^d   Stein, Z A ^c  

^a PHILADELPHIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c Columbia Univ Sch of Public Health ^*  (United States)

^d RUTGERS UNIVERSITY   (United States)

^e GLAXOSMITHKLINE   (United States)

^f NEW YORK ACADEMY OF MEDICINE   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SPERMICIDAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHLAMYDIASIS; CLINICAL EXAMINATION; CONDOM; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GONORRHEA; HEALTH PROMOTION; HUMAN; INCIDENCE; INFECTION PREVENTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PATIENT COUNSELING; PATIENT EDUCATION; PREVENTIVE HEALTH SERVICE; PREVENTIVE MEDICINE; PROSPECTIVE STUDY; PUBLIC HEALTH SERVICE; RACE DIFFERENCE; SYPHILIS; TREATMENT OUTCOME; TRICHOMONIASIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHLAMYDIA INFECTIONS; CONDOMS; CONDOMS, FEMALE; FEMALE; FOLLOW-UP STUDIES; GONORRHEA; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; ODDS RATIO; PHILADELPHIA; PROSPECTIVE STUDIES; SEXUALLY TRANSMITTED DISEASES; SYPHILIS; TRICHOMONAS VAGINITIS;

EID: 0038413823     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200305000-00010     Document Type: Article

References (33)

1. UNAIDS. Report on the global HIV/AIDS Epidemic. Geneva: World Health Organization, June 2000.
2. Van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomized controlled trial. Lancet 2002; 360:971-977.
3. Shervington D. The acceptability of the female condom among low-income African-American women. J Natl Med Assoc 1993; 85:341-347.
4. Gollub EL, Stein Z, el-Sadr W. Short-term acceptability of the female condom among staff and patients at a New York City Hospital. Fam Plann Perspect 1995; 4:155-158.
5. Ruminjo JK, Steiner M, Joanis C, Mwathe EG, Thagana N. Preliminary comparison of the polyurethane female condom with the latex male condom in Kenya. East Afr Med J 1996; 73:101-106.
6. UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development, Research Training in Human Reproduction. The Female Condom. Geneva: World Health Organization, 1997.
7. el-Bassel N, Krishnan SP, Schilling RF, Witte S, Gilbert L. Acceptability of the female condom among STD clinic patients. AIDS Educ Prev 1998; 10:465-480.
8. Sinpisut P, Chandeying V, Skov S, Uahgowitchai C. Perceptions and acceptability of the female condom [Femidom] amongst commercial sex workers in the Songkla province, Thailand. Int J STD AIDS 1998; 9:168-172.
9. Witte SS, el-Bassel N, Wada T, Gray O, Wallace J. Acceptability of female condom use among women exchanging street sex in New York City. Int J STD AIDS 1999; 3:162-168.
10. Artz L, Macaluso M, Brill I, et al. Effectiveness of an intervention promoting the female condom to patients at sexually transmitted disease clinics. Am J Public Health 2000; 90:237-244.
11. Farr G, Gabelnick H, Sturgen K, Dorflinger L. Contraceptive efficacy and acceptability of the female condom. Am J Public Health 1994; 84:1960-1964.
12. Trussell J, Sturgen K, Strickler J, Dominik R. Comparative contraceptive efficacy of the female condom and other barrier methods. Fam Plann Perspect 1994; 26:66-72.
13. Gollub EL. The female condom: tool for women's empowerment. Am J Public Health 2000; 90:1377-1381.
14. Mantell JE, Hoffman S, Weiss E, et al. The acceptability of the female condom: perspectives of family planning providers in New York City, South Africa, and Nigeria. J Urban Health 2001; 78:658-668.
15. Martin DJ. Inappropriate lubricant use with condoms by homosexual men. Public Health Reps 1992; 4:468-473.
16. Steiner M, Piedrahita C, Glover L, et al. The impact of lubricants on latex condoms during vaginal intercourse. Int J STD AIDS 1994; 5:29-36.
17. Sikkema KJ, Heckman TG, Kelly JA. HIV risk behaviors among innercity African American women. Women's Health 1997; 3:349-366.
18. Gollub EL, Stein ZA. The new female condom: item 1 on a women's AIDS prevention agenda. Am J Public Health 1993; 83:498-500.
19. Cates W Jr. The NIH Condom Report: the glass is 90% full. Fam Plann Perspect 2001; 33:231-233.
20. Davis KR, Weller SC. The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam Plann Perspect 1999; 31:272-279.
21. Drew WL, Blair M, Miner RC, Conant M. Evaluation of the virus permeability of a new condom for women. Sex Transm Dis 1990; 17:110-112.
22. Soper DE, Shoupe E, Shangold GA, Shangold MM, Gutmann J, Mercer L. Prevention of vaginal trichomoniasis by compliant use of the female condom. Sex Transm Dis 1993; 20:137-139.
23. Fontanet AL, Saba J, Chandelying V, et al. Protection against sexually transmitted diseases by granting sex workers in Thailand the choice of using the male or female condom: Results from a randomized controlled trial. AIDS 1998; 12:1851-1859.
24. Stein Z, Susser M. Annotation. Prevention of HIV, other sexually transmitted disease, and unwanted pregnancy - Testing physical barriers available to women. Am J Health 1998; 88:872-874.
25. Gollub EL, French P, Loundou A, Latka M, Rogers C, Stein Z. A randomized trial of hierarchical counseling in a short, clinic-based intervention to reduce the risk of sexually transmitted diseases in women. AIDS 2000; 14:1249-1255.
26. Latka M, Gollub E, French P, Stein Z. Male-condom and female- condom use among women after counseling in a risk-reduction hierarchy for STD prevention. Sex Transm Dis 2000; 27:431-437.
27. Centers for Disease Control and Prevention. Guideline for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998; 47(RR-1):1-116.
28. Goodman SN, Berlin JA. The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results. Ann Intern Med 1994; 121:200-206.
29. Schulz KF, Grimes DA. Unequal group sizes in randomized trials: guarding against guessing. Lancet 2002; 359:966-970.
30. Catania JA, Coates TJ, Stall R, et al. Prevalence of AIDS-related risk factors and condom use in the United States. Science 1992; 258: 1101-1106.
31. Musaba E, Morrison CD, Sunkutu MR, Wong EL. Long-term use of the female condom among couples at high risk of human immunodeficiency virus infection in Zambia. Sex Transm Dis 1998; 25:260-264.
32. Macaluso M, Demand M, Artz L, et al. Female condom use among women at high risk of sexually transmitted disease. Fam Plann Perspect 2000; 32:138-144.
33. Felbum PJ, Kuyon MA, Bwayo JJ, et al. Female condom introduction and sexually transmitted infection prevalence: results of a community intervention trial in Kenya. AIDS 2001; 15:1037-1044.